Related Experiment Video

Updated: Oct 8, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Unexpected flow cytometric results with two small GPIIb/IIIa blockers: eptifibatide and tirofiban

N Hézard, D Metz, S Tassan-Mangina

    Thrombosis and Haemostasis
    |April 20, 2001
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs04:15

    A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

    Published on: February 2, 2024

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells10:10

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

    Published on: October 27, 2009

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...